VCKA—>SCLX (Scilex Holding Co.) effective at tomorrow's open, pursuant to previously announced SPAC merger: https://www.globenewswire.com/news-release/2022/11/10/2553677/0/en/Scilex-Holding-Company-a-majority-owned-subsidiary-of-Sorrento-Therapeutics-Inc-Nasdaq-SRNE-Sorrento-Debuts-on-Nasdaq-Under-Ticker-SCLX.html Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.